Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
35.84
-1.19 (-3.21%)
Jun 13, 2025, 2:45 PM CST

Runben Biotechnology Revenue

Runben Biotechnology had revenue of 240.03M CNY in the quarter ending March 31, 2025, with 44.00% growth. This brings the company's revenue in the last twelve months to 1.39B, up 32.76% year-over-year. In the year 2024, Runben Biotechnology had annual revenue of 1.32B with 27.61% growth.

Revenue (ttm)
1.39B
Revenue Growth
+32.76%
P/S Ratio
10.44
Revenue / Employee
1.51M
Employees
921
Market Cap
14.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.32B285.22M27.61%
Dec 31, 20231.03B176.87M20.66%
Dec 31, 2022856.09M273.94M47.06%
Dec 31, 2021582.15M139.32M31.46%
Dec 31, 2020442.83M164.19M58.93%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition